Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

McNeil Supports Separate Alcohol, Stomach Bleeding Warnings For Ibuprofen

This article was originally published in The Tan Sheet

Executive Summary

McNeil Consumer & Specialty Pharmaceuticals endorses separate warnings for alcohol-related stomach bleeding and general gastrointestinal bleeding for 200 mg ibuprofen because the statements would target separate populations, the firm states in Sept. 2 comments to FDA

You may also be interested in...



Advil Label Comprehension Data Counter GI, Renal Warnings’ Merit – Wyeth

Almost 98% of participants in a recently conducted Advil label comprehension study understood that individuals who develop stomach pain after taking the OTC ibuprofen tablets should stop use, Wyeth Consumer Care reports

Aspirin, NSAID GI Bleeding Language Could Replace Alcohol Warning

Warnings detailing the risk of gastrointestinal bleeding with use of aspirin and other non-steroidal anti-inflammatory drugs should replace the current alcohol warning on such products, NDAC members asserted during a meeting in Silver Spring, Md. Sept. 20

Ibuprofen Detailed Renal, GI Warnings Required For Monograph Inclusion

Clinical study data and adverse event reports support inclusion of a warning on OTC ibuprofen labeling to alert consumers at risk for developing acute renal failure to consult a doctor, FDA says

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096013

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel